Replies to post #18982 on Radient Pharmaceuticals Corporation fka RXPC

[lakeshore555]

You think a takeover is coming.

An entity that wants to manufacture and/or sell DR-70 can license it for $100,000 per year, as UNI did. Radient has at least $18 million debt.

The choice is: assume $18 million debt and take over the company, or pay $100,000 and license DR-70.

You seriously think an entity would choose the former, not the latter?